MEDIZEN HUMANCARE Inc. (XKON:236340)
South Korea · Delayed Price · Currency is KRW 2,200.00
+100.00 (4.76%)
At close: Jul 31, 2026
MEDIZEN HUMANCARE Market Cap
MEDIZEN HUMANCARE has a market cap or net worth of 5.07 billion as of July 31, 2026. Its market cap has increased by 2.56% in one year.
Market Cap
5.07B
Enterprise Value
n/a
Revenue
583.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,200.00
ChartMarket Cap Chart
Since April 5, 2017, MEDIZEN HUMANCARE's market cap has decreased from 20.81B to 5.07B, a decrease of -75.64%. That is a compound annual growth rate of -14.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 5.07B | 29.41% |
| Dec 30, 2025 | 3.92B | -46.03% |
| Dec 30, 2024 | 7.26B | -21.25% |
| Dec 28, 2023 | 9.22B | -33.88% |
| Dec 29, 2022 | 13.94B | -13.57% |
| Dec 30, 2021 | 16.13B | -15.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 204.81B |
| DreamCIS | 60.27B |
| P&K Skin Research Center | 49.30B |
| Kolmar BioTech | 37.11B |
| HLB bioStep | 27.25B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 19.92B |
| C&R Research | 19.53B |